Company intelligence / Profile preview

PAXAFE

Indianapolis, Indiana, United Statespaxafe.com ↗

Ownership: Private
Development stage: Other

Overview

PAXAFE’s CONTXT platform has been commercially launched since April 2021. It delivers AI-powered risk quantification and prescriptive recommendations to optimize cold chain logistics for pharmaceuticals and perishables. The company partners with high-profile pharma manufacturers and service providers to ensure on-time, in-full delivery of temperature-sensitive products. No clinical results as the company does not develop drugs.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

CarrierTransposafeHive-Zox

Beyond the preview

Go deeper on PAXAFE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PAXAFE.

Explore the full profile